Technique for genetically modifying blood stem cells brings cure for blood diseases closer

The condition of mice with a genetic blood disease called beta-thalassemia improved significantly following treatment of their blood forming cells with a gene that enabled them to produce the type of hemoglobin normally found only in the fetus. These findings, by investigators at St. Jude Children's Research Hospital, are published in the October issue of Blood.

Beta-thalassemia is a genetic blood disease in which the red blood cells have an abnormal form of the oxygen-carrying molecule called hemoglobin (Hb). Normal Hb is made up of two alpha-globin proteins and two beta-globin proteins. The defective red blood cells in beta-thalassemia arise from hematopoietic stem cells (HSCs) in which both genes for beta-globin are either missing or mutated. In the absence of beta-globin, the other building block of Hb, alpha-globin, accumulates and eventually destroys the red blood cell. HSCs are parent cells in the bone marrow that give rise to blood cells.

The St. Jude team successfully treated beta-thalassemia in mice by using a newly developed vector--or biological ferry composed of DNA housed within a harmless virus--to shuttle a therapeutic gene into the defective HSCs. The gene allowed red cells that were derived from the HSCs to make gamma-globin, a protein that acted as a substitute for beta-globin. The resulting Hb molecule, composed of alpha- and gamma-globin, is called fetal Hb (HbF) because it normally occurs only during the fetal stage of development. The use of HbF prevents the need to introduce normal beta-globin into the body in someone who has never had it before. It is possible that the sudden introduction of beta-globin could trigger an immune response against this protein.

The vector, which used a virus called lentivirus to carry the gamma-globin gene, also carried a special set of additional pieces of DNA called regulatory elements. These elements were part of a section of the normal chromosome containing t

Contact: Bonnie Cameron
St. Jude Children's Research Hospital

Page: 1 2 3

Related biology news :

1. Technique quickly identifies bacteria for food safety, health care and homeland security
2. Technique used commonly in physics finds application in neuroscience
3. Technique makes it easier to see mouse embryo in all its glory
4. Technique offers new view of dynamic biological landscape
5. Technique provides new look on response of diseased canine heart
6. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
7. First all-African produced genetically engineered maize is resistant to maize streak virus
8. New study finds genetically engineered crops could play a role in sustainable agriculture
9. Nutrition and heredity are genetically linked
10. Scientists genetically engineer tomatoes with enhanced folate content
11. Cancer cells more likely to genetically mutate

Post Your Comments:

(Date:4/16/2019)... ... 2019 , ... The Healthcare Technology Report is pleased to ... process was run to evaluate the hundreds of CEOs that lead exemplary organizations ... related areas. We gathered data on each nominee’s professional background and assessed them ...
(Date:4/9/2019)... , ... April 09, 2019 , ... ... clinical outcomes, today announced a new partnership with Ambry Genetics, a leading clinical ... access to state-of-the-art clinical genetic testing and family history assessment, so they may ...
(Date:4/4/2019)... ... , ... The live session taking place on ... between product risk management (ISO 14971) and the clinical risk management process (ISO ... increasing global regulation and reimbursement challenges faced by medical device companies, it is ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... April 09, 2019 , ... To support the global fight ... Biohub (CZ Biohub) has chosen Geneious Biologics to help them analyze and compare ... efforts to establish new approaches to inform the discovery of antibody-based diagnostics, new ...
(Date:3/29/2019)... VIEW, Calif. (PRWEB) , ... March 28, 2019 ... ... achievement of development and testing milestones, CARB-X has proceeded with a second stage ... receive up to $1.7 million, which is on top of the $1.7 million ...
(Date:3/27/2019)... WESTBURY, N.Y. (PRWEB) , ... March 27, 2019 , ... ... booth #60 at the Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on ... Future and Pharma 4.0, two key tracks on the agenda this year. , Executives ...
(Date:3/19/2019)... ... 2019 , ... The AACR annual conference pulls together a diverse group of ... cancer research. The Visikol team will be at the show at booth #3252 and ... as their digital pathology services . “For AACR this year we are highlighting ...
Breaking Biology Technology:
Cached News: